Search tips
Search criteria 


Logo of aacPermissionsJournals.ASM.orgJournalAAC ArticleJournal InfoAuthorsReviewers
Antimicrob Agents Chemother. 2010 August; 54(8): 3535.
PMCID: PMC2916357

An Albumin-Conjugated Peptide Exhibits Potent Anti-HIV Activity and Long In Vivo Half-Life

Volume 54, no. 1, p. 191-196, 2010. Page 191: The author byline should include Cheryl A. Stoddart and Roger G. Ptak. The author byline and affiliation line should appear as shown above.

Page 193, column 1, lines 8 and 9: “under NIH contract NO1-AI-05415” should be deleted.

Page 193, column 1, line 28: “SCID/hu” should be “SCID-hu.”

Page 193, column 1, line 39: “SCID/hu” should be “SCID-hu.”

Page 194, column 2, line 35: “SCID/hu” should be “SCID-hu.”

Page 194, Table 1, footnote b: “against HIV-1IIIB” should be “in PBMCs.”

Page 195, Table 2 caption: “SCID/hu” should be “SCID-hu.”

Page 195, column 1, line 27: Before the word “Interestingly,” the following sentence should be added. “Our data showing sustained activity of the albumin-conjugated peptide FB006M is in agreement with studies of a similar C34 peptide albumin-conjugate (PC-1505) in SCID-hu Thy/Liv mice (20a).”

Page 195, Acknowledgments, lines 1 and 2: “NIH/NIAID contract NO1-AI-05415” should be “NIH/NIAID contract NO1-AI-05418.”

Page 195, Acknowledgments, line 8: “SCID/hu” should be “SCID-hu.”

Page 196: The following reference should be added.

20a. Stoddart, C. A., G. Nault, S. A. Galkina, K. Thibaudeau, P. Bakis, N. Bousquet-Gagnon, M. Robitaille, M. Bellomo, V. Paradis, P. Liscourt, A. Lobach, M. E. Rivard, R. G. Ptak, M. K. Mankowski, D. Bridon, and O. Quraishi. 2008. Albumin-conjugated C34 peptide HIV-1 fusion inhibitor: equipotent to C34 and T-20 in vitro with sustained activity in SCID-hu Thy/Liv mice. J. Biol. Chem. 283:34045-34052.

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)